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OBJECTIVE — Evidence that the metabolic syndrome is a risk factor for poor cognition is
mixed and is focused mainly on the elderly population; rarely is an adjustment made for socio-
economic factors. We examined this association in late midlife, with particular focus on cumu-
lative effects and the role of socioeconomic circumstances.
RESEARCH DESIGN AND METHODS — Analyses were performed for 4,150 white
participants from the Whitehall II study. Metabolic syndrome, using the National Cholesterol
Education Program Adult Treatment Panel III criteria, was assessed three times over the 10-year
follow-up (1991–2001). Cognitive function was assessed using a battery of six tests at the end of
the follow-up.
RESULTS — Afteradjustmentfordemographicvariables,healthbehaviors,andhealthstatus,
participants with persistent metabolic syndrome (at least two of the three screenings) over the
10-year follow-up had lower cognitive performance than participants who never had metabolic
syndrome. No signiﬁcant differences in cognitive function were observed between participants
with nonpersistent metabolic syndrome (one of the three screenings) and those who never had
metabolic syndrome during the follow-up. Adjustment for adult occupational position attenu-
ated this association by between 41 and 86%, depending on the measure of cognitive function.
Adjustment for education had little effect.
CONCLUSIONS — Only persistent metabolic syndrome was associated with lower cogni-
tiveperformanceinlatemidlife.Adultoccupationalpositionbutnoteducationhadasubstantial
impact on this association; these results highlight the importance of adult socioeconomic cir-
cumstances in identifying and targeting risk factors for cognitive aging.
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C
ardiovascular risk factors have in-
creasingly been recognized as im-
portant contributors to cognitive
outcomes such as dementia (1). The met-
abolic syndrome comprises ﬁve cardio-
vascular risk factors including abdominal
obesity, hypertriglyceridemia, low HDL
cholesterol, hypertension, and hypergly-
cemia (2). Numerous studies have shown
several of the individual components of
the metabolic syndrome to be linked to
theriskofcognitivedeclineanddementia
(3). However, the nature of the associa-
tion between metabolic syndrome and
cognitionremainsunclear.Thereareonly
a few studies on the metabolic syndrome
as a whole, and most of them have been
limited to elderly or older populations
(4–12). Furthermore, the ﬁndings are
mixed: although some reports suggest
that metabolic syndrome predicts
cognitive deﬁcit (4), cognitive decline
(5,11,12), and dementia (8,10), at least
two studies showed metabolic syndrome
to be associated with better cognitive per-
formance (6) and decelerated cognitive
decline (9). A further study found no sig-
niﬁcant relationship between metabolic
syndrome and dementia (7).
Severallimitationsinpreviousstudies
that are possible to overcome may have
contributed to inconsistencies in the evi-
dence. First, as subclinical manifestations
of dementia are believed to be present
many years before the diagnosis, examin-
ing the role of risk factors, such as the
metabolic syndrome, before old age
would provide insight into their impact
oncognitivefunction(13,14).Second,no
previousstudyhasexaminedtheeffectsof
persistent metabolic syndrome, assessed
repeatedly rather than at a single time
point, on cognition. Third, existing re-
search has not taken full account of the
potential for confounding by socioeco-
nomic position (SEP).
In this ﬁeld of research, SEP may play
a particularly important role as, on the
one hand, it contributes to cognitive re-
serve (15), and, on the other hand, it is
associated with vascular and other risk
factors for cognitive aging (16). Although
studies on the association between meta-
bolic syndrome and cognition usually ad-
just for education, they do not take into
accounttheeffectsoflaterlifemeasuresof
SEP.EducationreﬂectsearlySEPbutmay
not capture changes in socioeconomic
circumstances in adult life. Other mea-
sures, such as household income or occu-
pational position, may better reﬂect adult
socioeconomic circumstances.
We use data from a large prospective
middle-aged cohort (the Whitehall II
study) to examine the association between
metabolic syndrome and cognitive func-
tion in mid-life. Our focus is on investi-
gating the effect of cumulative exposure
to metabolic syndrome over 10 years and
the inﬂuence of SEP as indicated by edu-
cation and occupational position.
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METHODS— The target population
fortheWhitehallIIstudywasallLondon-
based ofﬁce staff (n  10,308), aged
35–55 years, working in 20 civil service
departments (17). After the ﬁrst medical
examination (phase 1, 1985–1988),
screenings by trained research staff were
repeated three times over a 19-year pe-
riod: phase 3 (1991–1993), phase 5
(1997–1999), and phase 7 (2003–2004).
Of the 10,308 participants in phase 1,
584 had died before phase 7, 1,182 had
withdrawn from the study, and 1,575 did
not respond at this phase of the follow-
up. The remaining 6,967 participants re-
sponded at phase 7 and, of these, 88.0%
had data on cognitive function at phase 7
(n  6,130), 71.0% (n  4,949) had data
on metabolic syndrome at phases 3, 5,
and7,and64.0%(n4,461)haddataon
all other covariates. The present analyses
are based on all white participants with
complete data (n  4,150). Ethical ap-
proval for the Whitehall II study was ob-
tained from the University College
LondonMedicalSchoolcommitteeonthe
ethics of human research.
Assessment of the metabolic
syndrome
The metabolic syndrome was deﬁned at
phases 3, 5, and 7, using the National
Cholesterol Education Program criteria
(2), based on the presence of three or
more of the following: waist circumfer-
ence for men 102 cm and for women
88 cm; serum triglycerides 1.7
mmol/l; HDL cholesterol for men 1.04
mmol/l and for women 1.29 mmol/l;
blood pressure 130/85 mmHg; and
fasting glucose 6.1 mmol/l. Waist cir-
cumference was taken as the smallest cir-
cumference below the costal margin.
Resting blood pressure was measured us-
ing the Hawksley random zero sphygmo-
manometer (phases 3 and 5) and the
OMRONHEM907(phase7).Serumtrig-
lycerides, HDL cholesterol, and fasting
blood glucose were analyzed as described
previously (18).
Assessment of cognitive function
Cognitive function was measured at
phase 7 and consisted of six standard
taskschosentoevaluatecomprehensively
cognitive functioning in middle-aged
white-collar workers. The tests were cho-
sen using the following criteria: assess-
ment of multiple cognitive domains,
ability to capture effects of age and other
risk factors in a middle-aged population,
and no ceiling or ﬂoor effects. More de-
tailsonthetests,describedinbriefbelow,
can be found elsewhere (19).
Short-term verbal memory was as-
sessedwitha20-wordfreerecalltest.Par-
ticipantswerepresentedalistof20words
(one or two syllables long) at 2-s intervals
andwerethenaskedtorecallinwritingas
many of the words as they could in any
order.
The Alice Heim 4-I (AH4-I) is com-
posed of a series of 65 verbal and mathe-
matical reasoning items of increasing
difﬁculty. It tests inductive reasoning,
measuring the ability to identify patterns
and infer principles and rules.
VocabularywasassessedwiththeMill
Hill Vocabulary test, in its multiple-
choice format, consisting of a list of 33
stimuluswordsorderedbyincreasingdif-
ﬁculty and six response choices.
Phonemic and semantic verbal ﬂu-
ency was assessed via “S” words for pho-
nemic ﬂuency and via “animal” words for
the semantic ﬂuency. Participants were
asked to recall in writing as many words
beginning with “S” and as many animal
names as they could in a given period of
time.
The 30-item Mini-Mental State Ex-
amination (MMSE) was used to assess
global cognitive status.
Assessment of covariates
All covariates (apart from educational at-
tainment)weremeasuredatphase7,con-
current with the measures of cognition.
Sociodemographic variables consisted of
age, sex, and marital status (married or
cohabiting, single, divorced, and wid-
owed). SEP was assessed using measures
of education, for early SEP, and occupa-
tional position, for mid-life SEP. Highest
educational attainment was measured at
phase 5 and grouped into ﬁve levels (no
academic qualiﬁcation, lower secondary
education, higher secondary education,
university degree, and higher university
degree).Current(orlastforretiredpartic-
ipants) British civil service employment
grade, deﬁned on the basis of salary, was
used as a measure of occupational posi-
tion and was grouped into three catego-
ries: high (senior administrators),
intermediate (executives, professionals,
and technical staff) and low (clerical and
ofﬁce support staff) grades. As of Au-
gust 1992 the salary range among high-
grade employees was £25,330–
£87,620 and among low-grade
employees was £7,387-£11,917.
Health behaviors measured were
smoking (current, former, and non-
smoker), frequency of alcohol consump-
tion(lessthanonceperweek,atleastonce
per week, and at least once per day), and
intensityofphysicalactivity(basedonfre-
quency and duration categorized as
“high,” “medium,” and “low”) (20).
Healthmeasuresconsideredintheseanal-
yses were depressive symptoms and cor-
onary heart disease (CHD). Depressive
symptoms were measured using the
4-item depression subscale (range 0–12)
of the 30-item General Health Question-
naire(21).Participantsscoring4onthis
depression subscale were deﬁned as hav-
ing depressive symptoms (18). Prevalent
CHD was identiﬁed using clinically veri-
ﬁed events, including nonfatal myocar-
dial infarction and deﬁnite angina as
described previously (22).
Statistical methods
Cognitive test scores were standardized
using T scores (mean 50, SD 10) to allow
comparisons among tests. We examined
theassociationbetweencumulativeexpo-
sure to metabolic syndrome, measured
three times over the 10-year follow-up
and cognitive functioning at phase 7. For
these analyses we categorized the three
measures of metabolic syndrome over the
10-years of follow-up as “never” having
metabolic syndrome, “nonpersistent” (1 of
3 screenings), and “persistent” (2o f3
screenings). ANCOVA was performed to
calculate adjusted mean differences in cog-
nitive T scores across the cumulative mea-
sure of metabolic syndrome, with “never
having metabolic syndrome” as the
reference.
ANCOVA was used to assess mean
differences in cognitive test scores as a
function of metabolic syndrome. For
these analyses, the adjustment for covari-
ates was performed in three steps. First, a
basicmodeladjustedforageandsex;then
a second model further adjusted for mar-
italstatus,healthbehaviors,andmeasures
of health status. Finally, education or oc-
cupational position was added sequen-
tiallytothebasicmodel(Fig.2)andtothe
second model (supplementary Tables A
and B, available in an online appendix at
http://care.diabetesjournals.org/cgi/content/
full/dc09-1218/DC1). Interactions among
covariates and frequency of metabolic
syndrome across the phases were tested
and found to be nonsigniﬁcant. The
level of statistical signiﬁcance was set at
P  0.05; marginal signiﬁcance was de-
ﬁned as 0.05  P  0.10. All analyses
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(version 9; SAS Institute, Cary, NC).
RESULTS— Compared with all 6,967
respondents at phase 7, participants in-
cluded in the current analyses (n 
4,150) were more likely to be men (73.9
vs. 64.8%), less likely to be in low occu-
pational positions (7.2 vs. 17.0%), and
less likely to have no academic qualiﬁca-
tion (8.1 vs. 10.0%). Participants ex-
cluded from the present analyses had
lower mean scores on all cognitive tests
(P  10
4) and a higher prevalence of
metabolic syndrome at phase 7 (20.0 vs.
10.9%, P  10
4) compared with those
included in the analysis.
An increase in the proportion of par-
ticipants with metabolic syndrome was
observed over the 10-year follow-up:
8.3% at phase 3, 8.9% at phase 5, and
11.0% at phase 7. Across the phases,
10.1% of participants showed nonpersis-
tent metabolic syndrome (1 of 3 screen-
ings), whereas 7.7% showed persistent
metabolic syndrome (2 of 3 screen-
ings). Characteristics of the participants
as a function of cumulative exposure to
the metabolic syndrome are presented in
Table 1. Participants with metabolic syn-
drome (persistent or not) were more
likely to be older and more likely to be
men. Smoking, low physical activity, and
high prevalence of CHD were more com-
mon in participants with the metabolic
syndrome. Although education was not
associated with the metabolic syndrome,
a higher proportion of participants in the
lowoccupationalpositiongrouphadmet-
abolic syndrome during follow-up.
Figure 1 shows the sex- and age-
adjusted mean differences in cognitive T
scores at phase seven for cumulative ex-
posure to the metabolic syndrome over
the 10-year follow-up. Compared with
participants who never had the meta-
bolic syndrome, those with persistent
exposure to the metabolic syndrome
had signiﬁcantly lower cognitive scores
on all tests except for the MMSE. How-
ever, no signiﬁcant differences were ob-




for education and then for occupational
position,onthescoredifferencesbetween
participants with persistent metabolic
syndrome and participants who never
had metabolic syndrome over the follow-
up, is shown in Fig. 2. After controlling
foreducation,participantswithpersistent
metabolic syndrome had lower scores on
memory, reasoning, vocabulary, and se-
mantic ﬂuency. In contrast, adjustment
for occupational position attenuated this
difference by 41% for memory, 86% for
reasoning, 48% for vocabulary, 65 and
Figure1—Meandifferences(95%CIs)incognitiveTscoresacrossthecumulativeexposuretothe
metabolic syndrome over the 10-year follow-up (n  4,150), adjusted for sex and age. *Mean
difference in cognitive T-scores statistically signiﬁcant (P  0.05). MS, metabolic syndrome.
Table 1—Characteristics of the population at phase 7 as a function of persistence of the
metabolic syndrome over the 10-year follow-up
Cumulative exposure to the metabolic syndrome
Never Nonpersistent Persistent P*
n 3,414 418 318
Female sex 27.0 21.8 22.3 0.02
Age (years) 60.5  5.9 61.4  5.9 61.4  6.1 0.001
Marital status, married or cohabited 77.5 74.6 72.3 0.15
Occupational position, lowest position 6.8 7.2 11.6 0.01
Education, no academic qualiﬁcation 7.8 10.3 8.5 0.24
Smoking habits, current smokers 10.7 12.4 11.0 10
4
Alcohol consumption, 1 drink/day 49.8 46.6 44.0 10
4
Physical activity, low 13.7 17.7 20.7 0.0004
CHD prevalence 5.3 8.1 12.3 10
4
Depressive symptoms 11.0 9.31 14.1 0.11
Central obesity criterion of metabolic
syndrome† 12.7 57.8 70.3 10
4
High triglyceride criterion of metabolic
syndrome† 14.4 53.6 75.8 10
4
Low HDL cholesterol criterion of
metabolic syndrome† 3.7 24.6 45.0 10
4
Hypertension criterion of metabolic
syndrome† 35.3 63.2 68.2 10
4
High fasting glucose criterion of
metabolic syndrome† 6.6 29.7 52.0 10
4
Data are % or means  SD. n  4,150. Nonpersistent metabolic syndrome was deﬁned as having it once
during the three screenings over the 10 years of follow-up. Persistent metabolic syndrome was deﬁned as
having it at least twice during the three screenings. *Results of the 
2 tests for heterogeneity. †Each criterion
of the metabolic syndrome was deﬁned using the National Cholesterol Education Program criteria (2). For
central obesity, there were eight missing values; for high triglyceride, low HDL cholesterol, and hyperten-
sion, there was one missing value; and for high fasting glucose criteria, there were ﬁve missing values.
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and 49% for the MMSE. After adjustment
for occupational position, no association
remained signiﬁcant between persistent
metabolic syndrome and cognitive test
scores,exceptforthatwiththevocabulary
test.
The analysis of the distribution of all
covariates, metabolic syndrome, and the
tests of cognition as a function of occupa-
tionalpositionshowed(supplementalTa-
bleA),ontheonehand,thatthelowerthe
occupational position, the lower the cog-
nitive scores and the higher the preva-
lence of persistent metabolic syndrome.
On the other hand, occupational position
was associated with all potential con-
founders of the metabolic syndrome–
cognitivefunctionrelationshipconsideredin
this analyses.
Analyses presented in Fig. 2 were re-
peated after taking into account the other
demographic factors, health behaviors,
and health status (supplemental Table B).
In the model including education, lower
cognitive T scores were observed in par-
ticipants with persistent metabolic syn-
drome over the 10-year follow-up
comparedwiththosewhoneverhadmet-
abolic syndrome. The associations were
statisticallysigniﬁcantforvocabulary(ad-
justed mean difference in T scores, m 
1.89 [95% CI 2.87 to 0.90], P 
0.0002) and semantic ﬂuency (m 
1.30 [2.37 to 0.24], P  0.02) and
marginally signiﬁcant for memory (m 
0.92 [2.01 to 0.18], P  0.10). How-
ever,theseassociationsweresubstantially
attenuated when education was replaced
by occupational position.
All the analyses presented so far used
the National Cholesterol Education Pro-
gram deﬁnition but were repeated using
the International Diabetes Federation
deﬁnition (http://www.idf.org/metabolic_
syndrome) of metabolic syndrome. In
general terms, the International Diabetes
Federation deﬁnition leads to greater
prevalence of metabolic syndrome and
somewhat smaller associations with cog-
nitivefunction.However,thegeneralpat-
tern of results was similar (results not
shown but available on request).
CONCLUSIONS— In this prospec-
tive cohort study of a middle-aged popu-
lation followed up for 10 years,
participants with persistent metabolic
syndrome had lower cognitive scores for
reasoning, vocabulary, semantic ﬂuency,
and, to a lesser extent, memory, com-
pared with participants who never had
metabolic syndrome. These associations
remained after adjustment for demo-
graphic variables, education, health be-
havior,andhealthstatus.Nodifferencein
cognitive function was observed between
participantswithnonpersistentmetabolic
syndrome and those who never had met-
abolic syndrome. Our study sheds light
on the impact of SEP on these relation-
ships:whereaseducationhadlittleimpact
onthemetabolicsyndrome–cognitionre-
lationship, occupational position sub-
stantially attenuated the association.
Thereisincreasinginterestinthepos-
sible impact of vascular and metabolic
disorders on dementia, and several stud-
ies have investigated this association in
elderly individuals. Two cross-sectional
studies showed that the presence of met-
abolic syndrome was associated with a
higher prevalence of Alzheimer’s disease
(10) and also with poorer cognitive func-
tion(4).Infourlongitudinalstudies,met-
abolic syndrome was shown to be
associatedwithagreatercognitivedecline
(5,11,12) and increased risk of all-cause
and vascular dementia (8). However, an-
other study did not show evidence of the
detrimental effect of metabolic syndrome
on dementia (7). Finally, two further
studies carried out in the oldest old indi-
viduals found the opposite: metabolic
syndrome was associated with better cog-
nition (6) and decelerated cognitive de-
cline (9).
The potential explanations for the
above inconsistencies include differences
in the length of follow-up, the sensitivity
of cognitive tests to detect a decline, the
low statistical power of several studies,
and survival bias in studies involving the
oldest old. Our study provides a further
explanation:themeasurementofthemet-
abolic syndrome at one point in time may
notcapturetheimpactoflong-termexpo-
sure to this syndrome as there is consid-
erable within-individual variation in
metabolicsyndromestatusovertime.Our
ﬁnding suggests that long-term exposure
to metabolic syndrome, persistent meta-
bolic syndrome rather than metabolic
syndrome status, at a given moment is as-
sociated with poor cognitive function.
Because poor cognition in midlife has
been shown to predict cognitive decline
and dementia later in life, the examina-
tion of the role of risk factors before old
age is important. It allows circumvention
of the problems of survival bias and re-
verse causality that may be common in
studies in the oldest age-groups. To date,
very few studies have investigated the ef-
fects of metabolic syndrome on cognition
in middle-age. Kalmijn et al. (14) showed
a long-term association between a cluster
of seven metabolic cardiovascular risk
factors measured at middle age and the
risk of dementia among men in old age,
but a recent cross-sectional study per-
formed in 853 participants aged 61 years
reported no association between meta-
bolicsyndromeandcognitivescores(13).
Thus, our observation of an association
Figure 2—Mean differences (95% CIs) in cognitive T scores between participants with persistent
metabolic syndrome and those with no metabolic syndrome after sequential adjustment for edu-
cation and occupational position. White bars, model 1: analyses adjusted for sex and age; light
gray bars, model 1 additionally adjusted for education; dark gray bars, model 1 additionally
adjusted for occupational position.
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and cognitive function in a large middle-
aged population constitutes a novel
ﬁnding.
Our ﬁndings emphasize the potential
importance of socioeconomic circum-
stances in the association between meta-
bolic syndrome and cognitive function.
By analyzing the relationship between
metabolic syndrome and cognition after
adjustment for a measure of early SEP,
here education, or alternatively a later life
measure of SEP, occupational position,
our study highlights the different impact
of these two measures. Education, al-
though extensively examined in relation
tocognitiveoutcomes,hasbeenshownin
several studies, including Whitehall II,
not to be associated with metabolic syn-
drome(5,6,13).Themodestimpactofed-
ucation on the metabolic syndrome–
cognition relationship observed in the
present study is consistent with ﬁndings
from other studies. On the other hand,
occupational position was strongly re-
lated to sociodemographic factors, health
behavior, and several health measures,
and the relationship between metabolic
syndrome and cognition was substan-
tially attenuated after adjustment for oc-
cupational position. To our knowledge,
no other study has taken into account the
effects of later life measures of SEP, such
as occupational position, making com-
parison with other studies difﬁcult.
The discrepant effect of adjustment
for education or occupational position
should be interpreted in light of the fact
that these measures cover different di-
mensions of SEP. Compared with educa-
tion, reached by the individual usually in
early adult life, midlife occupational posi-
tion more accurately reﬂects SEP condi-
tions over the adult life span. SEP is an
important determinant of mortality and
morbidity in many countries (23), and its
inﬂuence on health is believed to work in
several ways. Poor SEP is seen to increase
the biological vulnerability to diseases by
acting directly on physiological processes
but also through unhealthy behaviors
(24). Our report emphasizes the impor-
tance of taking into account SEP in the
metabolic syndrome–cognition relation-
shiptounderstandthepotentialimpactof
metabolic syndrome on cognitive aging.
Adjustment for occupational position at-
tenuated the association between persis-
tent metabolic syndrome and cognition
by between 41 and 86%. There are three
possible implications of our ﬁndings.
One, studies on cognitive aging that ad-
just for education to control the inﬂuence
of socioeconomic factors are clearly not
taking the socioeconomic environment of
older adults fully into account. Two,
given the size of the attenuation of the
association, it is possible that the ob-
served association between metabolic
syndrome and cognition is simply the re-
sult of confounding by socioeconomic
factors. This would imply that the ob-
served association is the result of the im-
pact of adult SEP on both metabolic
syndrome and cognitive function, and
there is no true causal effect of metabolic
syndrome on cognition. Three, given the
association between the components of
the metabolic syndrome and cognition
evident in the literature, it is possible that
“persistent” metabolic syndrome is a risk
factor for cognitive function. The attenu-
ation observed in our analysis could
therefore simply be due to occupational
position being a good proxy for factors
mediating the association between meta-
bolic syndrome and cognition. Further
researchisneededtodelineatetheprecise
mechanisms underlying the link between
metabolic syndrome and cognition.
Our report has several limitations.
First, the participants of the Whitehall
II study are mainly ofﬁce-based civil
servants, not fully representative of the
British population, and analysis was re-
stricted to “white” participants, which
may limit the generalizability of our ﬁnd-
ings.Second,weshowedthatparticipants
with lower cognitive performances or
with metabolic syndrome were less likely
to be included in our analyses. This
potential selection bias would probably
lead to underestimation of the relation-
ship between metabolic syndrome and
cognition. Finally, the use of a single as-
sessment of cognitive function is a limita-
tion as it does not allow conclusions to be
drawn on the direction of causality be-
tween metabolic syndrome and cognitive
decline.
In summary, this seems to be the ﬁrst
study to explore the association between
cumulative exposure to the metabolic
syndrome over a 10-year follow-up and
cognitive functioning in late midlife. Our
results suggest that rather than metabolic
syndrome status at a given moment per
se, the persistence of the syndrome is the
factorthathasadverseeffectsonlatercog-
nitive performances during adult life.
Furthermore, our report showed the dif-
ferent effects of SEP measures on the re-
lationship, depending on whether
education or occupational position was
considered; education had little impact,
but occupational position had a greater
impact.Theseresultshighlighttheimpor-
tance of the type of socioeconomic vari-
able in identifying and targeting risk
factors for cognitive aging.
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